Anders Aannestad is a senior associate in the San Diego office, specializing in patent litigation and counseling. Mr. Aannestad’s experience also includes patent and trademark prosecution, copyright registration and protection, the preparation of patent opinions of counsel, and intellectual property and commercial litigation.

Mr. Aannestad’s recent representations include:

• Abraxis BioScience, Inc. against Elan Pharma International, Ltd. in patent litigation involving Abraxis's albumin-bound paclitaxel for treatment of metastatic breast cancer.
• General Atomics, Diazyme Laboratories Division in winning summary judgment of noninfringement by Diazyme’s enzymatic homocysteine assay under two separate infringement theories against Axis-Shield ASA.
• The Regents of the University of California in litigation against the Monsanto Corporation leading to a settlement of over $200 million for a license to the University of California’s patents covering bovine growth hormone.
• Scantibodies Laboratories, Inc. against Nichols Institute Diagnostics, Inc. resulting in jury verdicts of invalidity and noninfringement by Scantibodies’ parathyroid hormone assay, and a finding of anticipation by the Federal Circuit.

Mr. Annestad’s publications include:

• Katherine L. Parker and Anders T. Aannestad, “An Assignment's Effect On Hypothetical Negotiation,” IP Law360, February 2008.
• David Doyle, Anders Aannestad, and Katherine Parker, “Description of Mouse Antibody Does Not Support Broad Patent Claiming Human and Other Antibodies,” San Diego Daily Transcript – Litigators in Science, January 2004.
• D.C. Doyle, E.M. Acker, A.T. Aannestad, P.A. Friedman, M.A.Woodmansee, “Is It Time To Revisit Unclean-Hands Doctrine?” The National Law Journal, May 14, 2001, p. C17.
• Pat E. Broom, Anders T. Aannestad, “Rule 68 Offers of Judgment -Problems Created By Duke v. Cochise County,” Arizona Attorney, August/September 1998, p. 28.
• M.E. Tischler, S. Satarug, A. Aannestad, K.A. Munoz, E.J. Henriksen, “Insulin Attenuates Atrophy of Unweighted Soleus Muscle by Amplified Inhibition of Protein Degradation,” Metabolism, June 1997; 46(6):673-9.
• K.A. Munoz, A. Aannestad, M.E., Tischler, E.J. Henriksen, “Skeletal Muscle Protein Content and Synthesis after Voluntary Running and Subsequent Unweighting,” Metabolism, August 1994; 43(8):994-9. E.J.
• Henriksen, K.A. Munoz, A.T. Aannestad, M.E. Tischler, “Cardiac Protein Content and Synthesis In Vivo After Voluntary Running or Head-Down Suspension,” J. Appl. Physiol, June 1994; 76(6):2814-9.

Mr. Aannestad received his Honors Bachelors of Science in Biochemistry from the University of Arizona (magna cum laude, 1993), and his Juris Doctor from the University of Arizona College of Law (summa cum laude, Order of the Coif, 1997).

Mr. Aannestad is admitted to practice in California and Arizona, and before the United States Patent and Trademark Office. He is a citizen of Norway and is fluent in Norwegian. Mr. Aannestad has competed in triathlons for the past twenty years, and has completed four Ironman distance triathlons, including the 1993 Hawaii Ironman World Championships.